$9.43
-$0.13
(-1.36%)
Quote as of 4:00 PM EST on 02/10/12
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
Extended Hours:
$9.43
$0.00
(0.00%)
Quote as of 5:15 PM EST on 02/10/12 (NASDAQ)
|
$9.43
-$0.13
(-1.36%)
|
|
| Today's Open | $9.44 |
|---|---|
| Previous Close | $9.56 |
| Daily Range | $9.31 - $9.59 |
| 52-Week Range | $6.42 - $10.60 |
| Market Cap | $671.83M |
| P/E Ratio | -7.30 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 157,068 |
| Average Daily Volume | 302,108 |
| Current FY EPS | -$1.25 |
RIGL Information
| Description |
|---|
| The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
The 2 Best-Performing Sectors Over the Last Decade
Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most
Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most
The New Pfizer: 6 Drug Companies With Bullish Short Trends
Better Late Than Never? Maybe.
Losing Biobucks as Pharma Reshuffles Its Deck
Mid-Day Update: Stocks Rally on Better-Than-Expected Jobs Report; Commodities Gain
Stocks Rally on New Jobs Data; Oil Adds Back Some of Prior-Session Loss
A Dedication to R&D Means These Stocks Could See Robust Growth
